<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 44-year-old Japanese male having <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) preceding <z:hpo ids='HP_0004820'>acute myelomonocytic leukemia</z:hpo> (AMMoL) with dysplastic marrow <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> (M4Eo in the FAB classification) is reported </plain></SENT>
<SENT sid="1" pm="."><plain>Sequential cytogenetic studies revealed a specific chromosomal abnormality, inv(16) (p13q22), when <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> was first diagnosed and again when overt leukemic transformation compatible with M4Eo was manifested </plain></SENT>
<SENT sid="2" pm="."><plain>However, during the interval between the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and AMMoL, an unrelated abnormal karyotype without inv(16), 47,XY,+9, was seen, when hematological data revealed remission after a low dose of <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> was administered </plain></SENT>
<SENT sid="3" pm="."><plain>In this patient eosinophils in the marrow were involved in the leukemic process cytogenetically, because a few metaphases overlaid with eosinophilic granules had the inv(16) with other numerical abnormalities </plain></SENT>
</text></document>